Gene: KCNJ12
Official Full Name: potassium inwardly rectifying channel subfamily J member 12provided by HGNC
Gene Summary: This gene encodes an inwardly rectifying K+ channel which may be blocked by divalent cations. This protein is thought to be one of multiple inwardly rectifying channels which contribute to the cardiac inward rectifier current (IK1). The gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00221 | KCNJ12 gRNA7-gRNA8 KO plasmid | KCNJ12 | $850 | |||
KO00634 | KCNJ12 Knockout cell line(Hep G2) | Human | KCNJ12 | 1:2~1:4 | Negative | Online Inquiry |
KO07292 | KCNJ12 Knockout cell line (HeLa) | Human | KCNJ12 | 1:3~1:6 | Negative | Online Inquiry |
KO07293 | KCNJ12 Knockout cell line (HCT 116) | Human | KCNJ12 | 1:2~1:4 | Negative | Online Inquiry |
KCNJ12 Gene Knockout Cell Lines are specialized cell lines engineered to specifically disrupt the KCNJ12 gene, which encodes a member of the potassium channel family (the inwardly rectifying potassium channel). These cell lines serve as vital tools for researchers seeking to investigate the physiological and pathological roles of potassium channels in cellular processes. By utilizing CRISPR-Cas9 or homologous recombination technologies, KCNJ12 knockout models provide insights into the gene's function, contributing to a deeper understanding of associated diseases like cardiac arrhythmias and neurological disorders.
The primary function of KCNJ12 is to mediate potassium ion flow across cellular membranes, which is crucial for maintaining membrane potential and cellular excitability. Disabling this gene allows researchers to explore the cellular ramifications of altered potassium homeostasis, studying critical aspects such as signal propagation in neurons and cardiac myocyte action potential modulation. This mechanistic insight can lay the groundwork for novel therapeutic targets in cardiovascular and neurological fields.
From a scientific standpoint, KCNJ12 Gene Knockout Cell Lines are indispensable in both basic research and clinical applications as they facilitate drug discovery and the development of gene therapies. Unlike other models, which may exhibit off-target effects or inconsistent gene expression, our knockout cell lines ensure precision in gene editing, thereby improving the reliability of experimental outcomes.
The unique selling points of these cell lines lie in their validated gene disruption efficiency and the adaptability for high-throughput screening applications. Researchers can confidently utilize these models to accelerate their investigations into potassium channel dynamics and their implications in human health.
By investing in KCNJ12 Gene Knockout Cell Lines, you are equipping yourself with a powerful resource that significantly enhances your ability to advance scientific inquiry and therapeutic innovation. Our company brings extensive expertise in genetic engineering and cell biology, ensuring that each product meets the highest standards of quality and reproducibility, thus empowering your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.